drugset / Trial / NCT05249634

Testosterone Treatment in Men With Chronic Kidney Disease

NCT05249634

NaSingle-groupOpen-labelTreatment

Summary

This study in being conducted in men who have low testosterone and chronic kidney disease. The investigators will evaluate the effects of an oral testosterone preparation, JATENZO, on testosterone levels and hemoglobin (red blood cells).

Timeline

Start
2022-03-15
Primary completion
2028-06
Completion
2028-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Undecanoate Small molecule Oral